Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV001366240 | SCV001562536 | uncertain significance | 3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome | 2022-10-24 | criteria provided, single submitter | clinical testing | This sequence change replaces leucine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 554 of the SERAC1 protein (p.Leu554Val). This variant is present in population databases (rs149034301, gnomAD 0.1%). This variant has not been reported in the literature in individuals affected with SERAC1-related conditions. ClinVar contains an entry for this variant (Variation ID: 1057290). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt SERAC1 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Ambry Genetics | RCV002548577 | SCV003604608 | uncertain significance | Inborn genetic diseases | 2022-02-09 | criteria provided, single submitter | clinical testing | The c.1660T>G (p.L554V) alteration is located in exon 15 (coding exon 14) of the SERAC1 gene. This alteration results from a T to G substitution at nucleotide position 1660, causing the leucine (L) at amino acid position 554 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Gene |
RCV003232328 | SCV003930217 | uncertain significance | not provided | 2023-05-30 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |
Ce |
RCV003232328 | SCV004156330 | likely benign | not provided | 2023-09-01 | criteria provided, single submitter | clinical testing | SERAC1: BP4 |